Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
2000 1
2001 1
2002 2
2004 2
2005 3
2006 1
2007 3
2008 2
2009 3
2010 6
2011 9
2012 13
2013 14
2014 16
2015 20
2016 18
2017 31
2018 56
2019 55
2020 64
2021 75
2022 54
2023 67
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

457 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Atrial fibrillation, familial, 14"
Page 1
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
López-López JA, Sterne JAC, Thom HHZ, Higgins JPT, Hingorani AD, Okoli GN, Davies PA, Bodalia PN, Bryden PA, Welton NJ, Hollingworth W, Caldwell DM, Savović J, Dias S, Salisbury C, Eaton D, Stephens-Boal A, Sofat R. López-López JA, et al. BMJ. 2017 Nov 28;359:j5058. doi: 10.1136/bmj.j5058. BMJ. 2017. PMID: 29183961 Free PMC article. Review.
Objective To compare the efficacy, safety, and cost effectiveness of direct acting oral anticoagulants (DOACs) for patients with atrial fibrillation.Design Systematic review, network meta-analysis, and cost effectiveness analysis. ...Apixaban 5 mg twice daily was ra …
Objective To compare the efficacy, safety, and cost effectiveness of direct acting oral anticoagulants (DOACs) for patients with atrial
A systematic review of the efficacy and safety of anticoagulants in advanced chronic kidney disease.
Parker K, Hartemink J, Saha A, Mitra R, Lewis P, Power A, Choudhuri S, Mitra S, Thachil J. Parker K, et al. J Nephrol. 2022 Nov;35(8):2015-2033. doi: 10.1007/s40620-022-01413-x. Epub 2022 Aug 25. J Nephrol. 2022. PMID: 36006608 Free PMC article. Review.

BACKGROUND: Patients with chronic kidney disease (CKD) have an increased risk of venous thromboembolism (VTE) and atrial fibrillation (AF). Anticoagulants have not been studied in randomised controlled trials with CrCl < 30 ml/min. ...Studies that evaluated both

BACKGROUND: Patients with chronic kidney disease (CKD) have an increased risk of venous thromboembolism (VTE) and atrial fibrillat
Pacing-induced cardiomyopathy: A systematic review and meta-analysis of definition, prevalence, risk factors, and management.
Somma V, Ha FJ, Palmer S, Mohamed U, Agarwal S. Somma V, et al. Heart Rhythm. 2023 Feb;20(2):282-290. doi: 10.1016/j.hrthm.2022.09.019. Epub 2022 Nov 7. Heart Rhythm. 2023. PMID: 36356656 Review.
The pooled prevalence of PiCM was 12% (95% confidence interval 11%-14%). In meta-analysis, risk factors included male sex, history of myocardial infarction, chronic kidney disease, atrial fibrillation, baseline left ventricular ejection fraction, native QRS d …
The pooled prevalence of PiCM was 12% (95% confidence interval 11%-14%). In meta-analysis, risk factors included male sex, history of …
Recurrent Ischemic Stroke - A Systematic Review and Meta-Analysis.
Kolmos M, Christoffersen L, Kruuse C. Kolmos M, et al. J Stroke Cerebrovasc Dis. 2021 Aug;30(8):105935. doi: 10.1016/j.jstrokecerebrovasdis.2021.105935. Epub 2021 Jun 18. J Stroke Cerebrovasc Dis. 2021. PMID: 34153594 Free article.
Based on a meta-analysis the summary proportion recurrence rate of recurrent stroke in studies using TOAST-criteria = 0.12 and = 0.14 in studies using TOAST-like criteria. Hypertension, diabetes mellitus, atrial fibrillation previous transient ischemic attack …
Based on a meta-analysis the summary proportion recurrence rate of recurrent stroke in studies using TOAST-criteria = 0.12 and = 0.14
Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis.
Ruddox V, Sandven I, Munkhaugen J, Skattebu J, Edvardsen T, Otterstad JE. Ruddox V, et al. Eur J Prev Cardiol. 2017 Sep;24(14):1555-1566. doi: 10.1177/2047487317715769. Epub 2017 Jun 15. Eur J Prev Cardiol. 2017. PMID: 28617620 Free PMC article. Review.
Background In contemporary atrial fibrillation trials most deaths are cardiac related, whereas stroke and bleeding represent only a small subset of deaths. We aimed to evaluate the long-term risk of cardiac events and all-cause mortality in individuals with atria
Background In contemporary atrial fibrillation trials most deaths are cardiac related, whereas stroke and bleeding represent o …
Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis.
McIntyre WF, Um KJ, Alhazzani W, Lengyel AP, Hajjar L, Gordon AC, Lamontagne F, Healey JS, Whitlock RP, Belley-Côté EP. McIntyre WF, et al. JAMA. 2018 May 8;319(18):1889-1900. doi: 10.1001/jama.2018.4528. JAMA. 2018. PMID: 29801010 Free PMC article. Review.
RESULTS: Twenty-three randomized clinical trials were identified (3088 patients; mean age, 61.1 years [14.2]; women, 45.3%). High-quality evidence supported a lower risk of atrial fibrillation associated with vasopressin treatment (RR, 0.77 [95% CI, 0.67 to 0 …
RESULTS: Twenty-three randomized clinical trials were identified (3088 patients; mean age, 61.1 years [14.2]; women, 45.3%). High-qua …
Dexmedetomidine for adult cardiac surgery: a systematic review, meta-analysis and trial sequential analysis.
Poon WH, Ling RR, Yang IX, Luo H, Kofidis T, MacLaren G, Tham C, Teoh KLK, Ramanathan K. Poon WH, et al. Anaesthesia. 2023 Mar;78(3):371-380. doi: 10.1111/anae.15947. Epub 2022 Dec 19. Anaesthesia. 2023. PMID: 36535747 Free article. Review.
The relative risk (95%CI) for postoperative delirium was 0.58 (0.43-0.78), p = 0.001; 0.76 (0.61-0.95) for atrial fibrillation, p = 0.015; and 0.49 (0.25-0.97) for short-term mortality, p = 0.041. ...
The relative risk (95%CI) for postoperative delirium was 0.58 (0.43-0.78), p = 0.001; 0.76 (0.61-0.95) for atrial fibrillation
Exercise-based cardiac rehabilitation for adults with atrial fibrillation.
Risom SS, Zwisler AD, Johansen PP, Sibilitz KL, Lindschou J, Gluud C, Taylor RS, Svendsen JH, Berg SK. Risom SS, et al. Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD011197. doi: 10.1002/14651858.CD011197.pub2. Cochrane Database Syst Rev. 2017. PMID: 28181684 Free PMC article. Review.
BACKGROUND: Exercise-based cardiac rehabilitation may benefit adults with atrial fibrillation or those who had been treated for atrial fibrillation. ...We included trials that included adults aged 18 years or older with atrial fibrillation
BACKGROUND: Exercise-based cardiac rehabilitation may benefit adults with atrial fibrillation or those who had been treated fo …
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis.
Li HL, Lip GYH, Feng Q, Fei Y, Tse YK, Wu MZ, Ren QW, Tse HF, Cheung BY, Yiu KH. Li HL, et al. Cardiovasc Diabetol. 2021 May 7;20(1):100. doi: 10.1186/s12933-021-01293-8. Cardiovasc Diabetol. 2021. PMID: 33962654 Free PMC article.
Randomized controlled trials that randomized patients with DM, CKD, or HF to SGLT2i or placebo were included. The outcomes of interest include atrial fibrillation (AF), embolic stroke, atrial flutter (AFL), AF/AFL, ventricular tachycardia (VT), and cardiac ar …
Randomized controlled trials that randomized patients with DM, CKD, or HF to SGLT2i or placebo were included. The outcomes of interest inclu …
Intravenous diltiazem versus metoprolol for atrial fibrillation with rapid ventricular rate: A meta-analysis.
Lan Q, Wu F, Han B, Ma L, Han J, Yao Y. Lan Q, et al. Am J Emerg Med. 2022 Jan;51:248-256. doi: 10.1016/j.ajem.2021.08.082. Epub 2021 Nov 6. Am J Emerg Med. 2022. PMID: 34781150
BACKGROUND: Intravenous diltiazem and metoprolol are both commonly used to treat atrial fibrillation (AF) with rapid ventricular rate (RVR) in the emergency department (ED), but the advantages and disadvantages of these drugs cannot be verified. ...The results of th …
BACKGROUND: Intravenous diltiazem and metoprolol are both commonly used to treat atrial fibrillation (AF) with rapid ventricul …
457 results